Inventor
Markus Manz
Inventor
Zollikon, CH
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A01Kprimary
A01KAnimal husbandry21%
C07KPeptides21%
C12NMicroorganisms or enzymes20%
A61KPreparations for medical, dental or toiletry purposes16%
Y02ATechnologies for adaptation to climate change7%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations2%
A63FCard, board, or roulette games1%
C12YEnzymes1%
PatentTitleYear
11,051,499Genetically modified mice and engraftment202111,026,408Genetically modified non-human animals and methods of use thereof202110,785,966Humanized M-CSF mice202010,785,968Genetically modified non-human animals and methods of use thereof202010,561,126Genetically modified non-human animals and methods of use thereof202010,463,028Genetically modified non-human animals expressing human EPO201910,433,527Genetically modified non-human animals and methods of use thereof201910,278,374Genetically modified mice and engraftment201910,123,518Genetically modified non-human animals and methods of use thereof20189,986,724Genetically modified non-human animals and methods of use thereof20189,901,082'Genetically modified non-human animals and methods of use thereof'20189,839,208'Human SIRPα transgenic mice and their methods of use'20179,820,476'Genetically modified non-human animals and methods of use thereof'20179,655,352'Humanized M-CSF mice'20179,554,563'Genetically modified mice and engraftment'20179,402,377'Human SIRPAalpha transgenic animals and their methods of use'20169,301,509'Genetically modified mice and engraftment'20168,847,004'Humanized M-CSF mice'20148,692,052'Genetically modified mice and engraftment'20148,541,646'Genetically modified mice and engraftment'20137,618,654'Mammalian myeloid progenitor cell subsets'20097,300,760'Mammalian myeloid progenitor cell subsets'20076,761,883'Mammalian myeloid progenitor cell subsets'2004Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2004–2009Based in Palo Alto, CA, US· patent location history
2013–2021Patents assigned to UNIV YALE (20)· patent assignee history
2013–2021Patents assigned to REGENERON PHARMA (18)· patent assignee history
2013–2016Patents assigned to EYNON ELIZABETH (5)· patent assignee history
2013–2016Patents assigned to MANZ MARKUS (5)· patent assignee history
2013–2017Based in Zurich, CH· patent location history
2014–2021Based in Zollikon, CH· patent location history
2018–2021Patents assigned to INSTITUTE FOR RES IN BIOMEDICINE IRB (11)· patent assignee history
2019Based in Bellinzona, CH· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV YALE | 20 | 2013–2021 |
| REGENERON PHARMA | 18 | 2013–2021 |
| INSTITUTE FOR RES IN BIOMEDICINE IRB | 11 | 2018–2021 |
| EYNON ELIZABETH | 5 | 2013–2016 |
| MANZ MARKUSself | 5 | 2013–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Zollikon, CH | 15 | 2014–2021 |
| Zurich, CH | 4 | 2013–2017 |
| Palo Alto, California, US | 3 | 2004–2009 |
| Bellinzona, CH | 1 | 2019 |